Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study - 28/10/21
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
| pagine | 9 |
| Iconografia | 1 |
| Video | 0 |
| Altro | 0 |
Highlights |
• | Two-thirds of digestive cancer patients receive chemotherapy within the last 3 months of life. |
• | Young patients and patients with aggressive disease receive more end-of-life chemotherapy. |
• | Palliative care team intervention is associated with less administration of chemotherapy in the last month of life. |
• | Patients who receiving EOL chemotherapy die more often in oncology units than at home or in palliative care unit. |
Abstract |
Background |
The use of chemotherapy (CT) near the end-of-life (EOL) is an important issue in oncology since it could degrade quality of life. CT near EOL is still poorly studied, with no dedicated study in gastrointestinal (GI) cancer patients.
Aim |
To analyze in GI cancer patients the factors associated with the use of CT within 3- and 1-month before patients’ death.
Methods and participants |
All consecutive patients who died from a GI cancer in 10 French tertiary care hospitals during 2014 were included in this retrospective study. Clinical, demographical and biological data were collected and compared between patients receiving or not CT within 3- and 1-month before death. Variables associated with overall survival (OS) was also determined using of univariate and multivariate analyses with a Cox model.
Results |
Four hundred and thirty-seven patients with a metastatic GI cancer were included in this study. Among them, 293 pts (67.0%) received CT within 3-months before death, and 121 pts (27.7%) received CT within 1-month before death. Patients receiving CT within 3-months before death were significantly younger (median age: 65.5 vs 72.8 years, p < 0.0001), with a better PS (PS 0 or 1: 53.9 vs 29.3%, p < 0.0001) and a higher albumin level (median: 32.8 vs 31.0 g/L, p = 0.048). Similar results were found for CT within 1 month before death. Palliative care team intervention was less frequent in patients who received CT in their last month of life (39.7% vs 51.3%, p = 0.02). In multivariate analysis, median OS from diagnosis was shorter in the group receiving CT within 1-month before death (HR = 0.59; 95% CI [0.48–0.74]).
Conclusion |
In GI-cancer patients, CT is administered within 3- and 1-month before death, in two and one third of patients, respectively. Patients receiving CT within 1-month before death, had more aggressive disease with poor OS. Palliative care team intervention was associated with less administration of CT in the last month of life. These results highlight the need to better anticipate the time to stop CT treatment in the end-of-life and the importance of an active collaboration between oncology and palliative care teams.
Il testo completo di questo articolo è disponibile in PDF.Abbreviations : EOL, CT, GI, OS, QOL, PCU, PCT
Keywords : End-of-life chemotherapy, Palliative care, Digestive oncology, Palliative care team, Aggressiveness of end-of-life care
Mappa
Vol 45 - N° 5
Articolo 101709- Settembre 2021 Ritorno al numero
Articolo precedente
- A study of leptin and its gene 2548 G/A Rs7799039 single-nucleotide polymorphisms in Egyptian children: A single-center experience
- Amal Ahmed Mohamed, Hoda H. Ahmed, Sanaa M. ElSadek, Rasha S. Mohamed, Reham Y. El-Amir, Wafaa Salah, Eman Sultan, Dalia M. Abd El-Hassib, Hanan M. Fouad
- Quality improvement opportunities exist for Helicobacter pylori treatment and confirmatory testing
- Natalie Rodriguez, Amanda G. Kennedy, Bradley J. Tompkins, Jocelyn VanOpdorp, Jason Heffley, Eric Ganguly
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?